Acipimox

Key Product Details

Product Description

Acipimox is a antilipolytic agent; lowers plasma free fatty acid (FFA), triglyceride (TG), glucose and insulin levels and increases leptin levels.

Product Specifications for Acipimox

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Solubility

Preparing Stock Solutions for Acipimox

The following data is based on the product molecular weight 154.12.

Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:

1 Recalculate

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	6.49 mL	32.44 mL	64.88 mL
5 mM	1.30 mL	6.49 mL	12.98 mL
10 mM	0.65 mL	3.24 mL	6.49 mL
50 mM	0.13 mL	0.65 mL	1.30 mL

Calculators

Background References

References are publications that support the biological activity of the product.

• Lovisolo Pharmacological proflie of a new antilipolytic agent: 5-methyl-pyrazine-2-carboxylic acid 4-oxide (acipimox) II - Antilipolytic and blood lipid lowering activitiy Pharmacol.Res.Comms.
• Christie Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes. Diabetol.
• Wang-Fisher Acipimox stimulates leptin production from isolated rat adipocytes. J.Endocrinol. 2002 PMID: 12176665

Product Documents for Acipimox